PPARA and COVID-19: Therefore, considering the anti-inflammatory importance of PPARs to control the hyperinflammatory response during COVID-19, further research should deeply investigate the individual or collective effects of PPAR subtypes to inhibit cytokine storms during SARS-CoV-2 infection.